´ç´¢º´ ½ÃÀåÁ¶»çº¸°í¼­

´ç´¢º´ °ü·Ã Á¶»çº¸°í¼­¿¡¼­´Â ´ç´¢º´ °ü·Ã Á¦Ç° ½ÃÀåÀÇ Ãֽе¿Çâ¿¡ ´ëÇØ Æø³Ð°Ô ´Ù·ç¾ú½À´Ï´Ù. ¶ÇÇÑ Ä¡·á¹ý°ú Àν¶¸°, Àν¶¸° Àü´Þ ½Ã½ºÅÛ, ¿ªÇÐÀû »óȲ, ȯÀÚ Àα¸ ¹× ¿¬·É ±¸Á¶, À¯º´ÀÚ¼ö, °Ë»ç ¹æ¹ý µî¿¡ °üÇÑ »ó¼¼ÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. °¢±¹ ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ Àü¸Á¿¡ °üÇÑ º¸°í¼­µµ ´Ù¼ö ±¸ºñÇϰí ÀÖ½À´Ï´Ù.

1 - 25 (Àüü: 254°Ç)
¼¼°èÀÇ ´ç´¢º´¼º À§¸¶ºñ Ä¡·á ½ÃÀå
Diabetic Gastroparesis Treatment
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,015,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ °æ±¸¿ë Ç×´ç´¢º´Á¦ ½ÃÀå - »ê¾÷±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ÀǾàǰº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Oral Anti-Diabetic Drugs Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drugs, By End Users, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,165,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ 1Çü ´ç´¢º´ ½ÃÀå
Type 1 Diabetes
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,015,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ³»´ç´É °Ë»ç ½ÃÀå
Glucose Tolerance Tests
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,015,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ À§¸¶ºñ Ä¡·á ½ÃÀå
Gastroparesis Treatment
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 5,850 £Ü 8,015,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢Áö¹æ»ý±«»ç(NLD) ½ÃÀå º¸°í¼­(2025³â)
Necrobiosis Lipoidica Diabeticorum (NLD) Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,151,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ºñÁÖ»ç Àν¶¸° ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - Á¦Ç°º°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ ºÎ¹®(2020-2030³â)
Non-Injectable Insulin Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Product, By Distribution Channel, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,500 £Ü 6,165,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÓÈ¿¼º Àν¶¸° ½ÃÀå ±Ô¸ð ¹× Á¡À¯À² ºÐ¼® - ¼ºÀå µ¿Çâ°ú ¿¹Ãø(2025-2033³â)
Rapid Acting Insulin Market Size and Share Analysis - Growth Trends and Forecast Report 2025-2033
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 2,990 £Ü 4,096,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼ÓÈ¿¼º Àν¶¸° ½ÃÀå º¸°í¼­(2025³â)
Short-Acting Insulin Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,151,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º ¸»ÃʽŰ溴Áõ ½ÃÀå º¸°í¼­(2025³â)
Diabetic Peripheral Neuropathy Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,151,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º Ȳ¹ÝºÎÁ¾(DME) ½ÃÀå º¸°í¼­(2025³â)
Diabetic Macular Edema (DME) Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,151,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º ÄÉÅæ»êÁõ(DKA) ½ÃÀå º¸°í¼­(2025³â)
Diabetic Ketoacidosis (DKA) Global Market Report 2025
¹ßÇà 2025³â 05¿ù
°¡°Ý US $ 4,490 £Ü 6,151,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð : ¾àÁ¦º°, ´ç´¢º´ À¯Çüº°, À¯Åë ä³Îº°, Áö¿ª ¹üÀ§º° ¹× ¿¹Ãø
Global Diabetes Drugs Market Size By Drug (Injectable Drugs, Oral Drugs), By Diabetes Type (Type 1, Type 2), By Distribution Channel (Hospital Pharmacies, Rental Pharmacies, Online Pharmacies), By Geographic Scope and Forecast
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,950 £Ü 5,411,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àӽżº ´ç´¢ ½ÃÀå º¸°í¼­(2025³â)
Gestational Diabetes Global Market Report 2025
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,490 £Ü 6,151,000 (ºÎ°¡¼¼ º°µµ)
´ç´¢º´¼º À§¸¶ºñ Ä¡·á ½ÃÀå : ¼¼°è »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø - À¯Çüº°(µî±Þ 2, µî±Þ 3), ¾à¹° Á¾·ùº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°, °æÀﺰ(2020-2030³â)
Diabetic Gastroparesis Treatment Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type (Grade 2, Grade 3), By Drug Class, By Route of Administration, By Distribution Channel By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,165,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ Àν¶¸° ½ÃÀå : Á¦Ç° À¯Çüº°, ¿ëµµº°, À¯Åë ä³Îº°, Áö¿ªº°, ±âȸ ¹× ¿¹Ãø(2018-2032³â)
Insulin Market Assessment, By Product, By Type, By Application, By Distribution Channel, By Region, Opportunities and Forecast, 2018-2032F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,800 £Ü 6,576,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ ¸Á¸·Áõ ½ÃÀå : ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(À¯Çüº°, °ü¸®¹ýº°, Áö¿ªº°), ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Diabetic Retinopathy Market Size, Share & Trends Analysis Report By Type (Proliferative Diabetic Retinopathy), By Management (Anti-VEGF, Intraocular Steroid Injection, Laser Surgery, Vitrectomy), By Region And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 5,950 £Ü 8,152,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º Á·±Ë¾ç Ä¡·áÁ¦ ½ÃÀå : ¾÷°è ºÐ¼®, ±Ô¸ð, Á¡À¯À², ¼ºÀå, µ¿Çâ, ¿¹Ãø(2025-2032³â)
Diabetic Foot Ulcer Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,995 £Ü 6,843,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ¼¼¸¶±Û·çƼµå(Semaglutide) ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(Á¦Ç°º°, ¿ëµµº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°), ºÎ¹®º° ¿¹Ãø(2025-2035³â)
Semaglutide Market Size, Share & Trends Analysis Report By Product (Ozempic, Wegovy, Rybelsus), By Application (Type 2 Diabetes Mellitus, Obesity), By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2035
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 5,950 £Ü 8,152,000 (ºÎ°¡¼¼ º°µµ)
´ç´¢º´ ÀüÁõ½ÃÀå : »ê¾÷ ±Ô¸ð, Á¡À¯À², µ¿Çâ, ±âȸ, ¿¹Ãø, ¾àÁ¦ Ŭ·¡½ºº°, ¿¬·ÉÃþº°, Áö¿ªº°, °æÀï(2020-2030³â)
Prediabetes Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Drug Class, By Age Group, By Region and Competition, 2020-2030F
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,500 £Ü 6,165,000 (ºÎ°¡¼¼ º°µµ)
Ç×´ç´¢º´Á¦ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¾àÁ¦ Ŭ·¡½ºº°, ´ç´¢ À¯Çüº°, Åõ¿© °æ·Îº°, À¯Åë ä³Îº°, Áö¿ªº°, ºÎ¹® ¿¹Ãø(2025-2030³â)
Antidiabetics Market Size, Share & Trends Analysis Report By Drug Class, By Diabetes Type, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 5,950 £Ü 8,152,000 (ºÎ°¡¼¼ º°µµ)
´ç´¢º´ ÀüÁõ ½ÃÀå ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м® º¸°í¼­ : ¾àÁ¦ Ŭ·¡½ºº°, ¿¬·ÉÃþº°, Áö¿ªº°, ºÎ¹®º° ¿¹Ãø(2025-2030³â)
Prediabetes Market Size, Share & Trends Analysis Report By Drug Class (Diguanide, Thiazolidinediones, Glucagon-like Peptide-1 Agonists (GLP-1), DPP-4 Inhibitors), By Age Group (Children, Adult, Elderly), By Region, And Segment Forecasts, 2025 - 2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 5,950 £Ü 8,152,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´ Ä¡·áÁ¦ ½ÃÀå ¿¹Ãø(-2032³â) : Á¦Ç°, ´ç´¢º´ À¯Çü, ÇüÅÂ, À¯Åë ä³Î, Áö¿ªº° ºÐ¼®
Diabetes Drugs Market Forecasts to 2032 - Global Analysis By Product (Insulin, Oral Anti-Diabetic Drugs, Injectable Non-Insulin Drugs and Combination Drugs), Diabetes Type, Formulation, Distribution Channel and By Geography
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 4,150 £Ü 5,685,000 (ºÎ°¡¼¼ º°µµ)
Àü´ç´¢º´ ½ÃÀå : ÇöȲ ºÐ¼® ¹× ¿¹Ãø(2025-2033³â)
Prediabetes Market: Current Analysis and Forecast (2025-2033)
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,999 £Ü 5,479,000 (ºÎ°¡¼¼ º°µµ)
¼¼°èÀÇ ´ç´¢º´¼º ¸Á¸·Áõ : Á¦Ç° À¯Çü, ´ç´¢º´ À¯Çü, ȯÀÚ À¯Çü, ÃÖÁ¾»ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)
Diabetic Retinopathy Market by Product Type, Diabetic Type, Patient Type, End-User - Global Forecast 2025-2030
¹ßÇà 2025³â 04¿ù
°¡°Ý US $ 3,939 £Ü 5,396,000 (ºÎ°¡¼¼ º°µµ)
(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.